PF-04691502 Uses, Dosage, Side Effects and more
PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
| Attribute | Details |
|---|---|
| Trade Name | PF-04691502 |
| Generic | PF-04691502 |
| Type | |
| Formula | C22H27N5O4 |
| Weight | Average: 425.4809 Monoisotopic: 425.206304377 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
